Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 2
2001 3
2003 6
2004 4
2005 6
2006 5
2007 12
2008 9
2009 16
2010 5
2011 19
2012 20
2013 27
2014 13
2015 18
2016 13
2017 26
2018 17
2019 21
2020 17
2021 25
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

262 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: havrilesky l. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: havrilesky l. Clin Cancer Res. 2020 Aug 1;26(15):3928-3935. doi: 10.1158/1078-0432.CCR-20-0953. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601075 Free PMC article. Clinical Trial.
Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Gierisch JM, et al. Among authors: havrilesky lj. Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1931-43. doi: 10.1158/1055-9965.EPI-13-0298. Epub 2013 Sep 6. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24014598 Review.
Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD. Myers ER, et al. Among authors: havrilesky lj. JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. JAMA. 2015. PMID: 26501537 Review.
Association of Medicaid expansion with mortality from gynecologic cancers.
Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Albright BB, et al. Among authors: havrilesky lj. Am J Obstet Gynecol. 2021 Mar;224(3):323-325. doi: 10.1016/j.ajog.2020.11.024. Epub 2020 Nov 20. Am J Obstet Gynecol. 2021. PMID: 33221294 Free PMC article. No abstract available.
In reply.
Havrilesky LJ, Myers ER, Thomas WL. Havrilesky LJ, et al. Obstet Gynecol. 2013 Nov;122(5):1114. doi: 10.1097/01.AOG.0000435077.65209.72. Obstet Gynecol. 2013. PMID: 24150023 No abstract available.
Management of adnexal mass.
Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE, Gray RN, McCrory DC. Myers ER, et al. Among authors: havrilesky lj. Evid Rep Technol Assess (Full Rep). 2006 Feb;(130):1-145. Evid Rep Technol Assess (Full Rep). 2006. PMID: 17854238 Free PMC article. Review.
262 results